Cambrex célèbre l’inauguration d’une nouvelle installation de Q1 Scientific en Belgique et obtient son premier accord commercial de stockage de stabilité USA – Français USA – English USA – English USA – español Latin America – español Brazil – Português USA – Deutsch

EAST RUTHERFORD, New Jersey, 31 mai 2023 /PRNewswire/ — Cambrex, une importante organisation mondiale de développement et de fabrication sous contrat (CDMO), qui fournit des substances pharmaceutiques, des produits pharmaceutiques et des services d’analyse tout au long du cycle de vie des médicaments, a célébré hier l’inauguration de la nouvelle installation de Q1 Scientific en Belgique … Read more

Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement

EAST RUTHERFORD, N.J, May 31, 2023 /PRNewswire/ — Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, … Read more

Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement

EAST RUTHERFORD, N.J, May 31, 2023 /PRNewswire/ — Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, … Read more

Cambrex achève l’agrandissement des installations de Snapdragon Chemistry à Waltham, dans le Massachusetts

EAST RUTHERFORD, N.J., 16 mai 2023 /PRNewswire/ — Cambrex, un leader mondial dans le domaine de la fabrication et du développement sous contrat (CDMO) qui fournit des substances médicamenteuses, des produits pharmaceutiques et des services analytiques tout au long du cycle de vie des médicaments, a annoncé aujourd’hui que Snapdragon Chemistry avait achevé la deuxième phase de … Read more

Cambrex conclui expansão da unidade da Snapdragon Chemistry em Waltham, Massachusetts

EAST RUTHERFORD, Nova Jersey, 16 de mayo de 2023 /PRNewswire/ — Hoje, a Cambrex, uma organização líder global em desenvolvimento e fabricação por contrato (CDMO) fornecendo substância farmacêutica, produto farmacêutico e serviços analíticos em todo o ciclo de vida do medicamento, anunciou que a Snapdragon Chemistry concluiu a segunda fase de sua expansão de 51 … Read more